SCD1/FADS2 Fatty Acid Desaturases Equipoise Lipid Metabolic Activity and Redox-driven Ferroptosis in Ascites-derived Ovarian Cancer Cells

Overview

Journal Theranostics

Date 2022 May 13

PMID 35547771

Authors

Yang Xuan

Huogang Wang

Mingo Mh Yung

Fushun Chen

Wai-Sun Chan

Yau-Sang Chan

Stephen Kw Tsui

Hextan Ys Ngan

Karen Kl Chan

David W Chan

Affiliations

Soon will be listed here.

Abstract

Malignant ascites in peritoneal metastases is a lipid-enriched microenvironment and is frequently involved in the poor prognosis of epithelial ovarian cancer (EOC). However, the detailed mechanisms underlying ovarian cancer (OvCa) cells dictating their lipid metabolic activities in promoting tumor progression remain elusive. The omental conditioned medium (OCM) was established to imitate the omental or ascites microenvironment. Mass spectrometry, RT-qPCR, IHC, and western blot assays were applied to evaluate human fatty acid desaturases expressions and activities. Pharmaceutical inhibition and genetic ablation of SCD1/FADS2 were performed to observe the oncogenic capacities. RNA sequencing, lipid peroxidation, cellular iron, ROS, and Mito-Stress assays were applied to examine ferroptosis. OvCa patient-derived organoid and mouse model of peritoneal metastases were used to evaluate the combined effect of SCD1/FADS2 inhibitors with cisplatin. We found that two critical fatty acid desaturases, stearoyl-CoA desaturase-1 (SCD1) and acyl-CoA 6-desaturase (FADS2), were aberrantly upregulated, accelerating lipid metabolic activities and tumor aggressiveness of ascites-derived OvCa cells. Lipidomic analysis revealed that the elevation of unsaturated fatty acids (UFAs) was positively associated with SCD1/FADS2 levels and the oncogenic capacities of OvCa cells. In contrast, pharmaceutical inhibition and genetic ablation of SCD1/FADS2 retarded tumor growth, cancer stem cell (CSC) formation and reduced platinum resistance. Inhibition of SCD1/FADS2 directly downregulated GPX4 and the GSH/GSSG ratio, causing disruption of the cellular/mitochondrial redox balance and subsequently, iron-mediated lipid peroxidation and mitochondrial dysfunction in ascites-derived OvCa cells. Combinational treatment with SCD1/FADS2 inhibitors and cisplatin synergistically repressed tumor cell dissemination, providing a promising chemotherapeutic strategy against EOC peritoneal metastases.

Citing Articles

A Pilot Study on Qualitative Metabolomics to Characterize Lewis Lung Carcinoma in Mice.

Stawarska A, Bamburowicz-Klimkowska M, Pisklak D, Gawlak M, Grudzinski I Life (Basel). 2025; 15(2).

PMID: 40003611 PMC: 11857005. DOI: 10.3390/life15020202.

Attenuated growth factor signaling during cell death initiation sensitizes membranes towards peroxidation.

Gollowitzer A, Pein H, Rao Z, Waltl L, Bereuter L, Loeser K Nat Commun. 2025; 16(1):1774.

PMID: 40000627 PMC: 11861335. DOI: 10.1038/s41467-025-56711-2.

Niraparib restricts intraperitoneal metastases of ovarian cancer by eliciting CD36-dependent ferroptosis.

Jin N, Qian Y, Jiao X, Wang Z, Li X, Pan W Redox Biol. 2025; 80:103528.

PMID: 39922130 PMC: 11851289. DOI: 10.1016/j.redox.2025.103528.

Targeting ferroptosis: a promising approach for treating lung carcinoma.

Wu Z, Zhang Y, Zhong W, Wu K, Zhong T, Jiang T Cell Death Discov. 2025; 11(1):33.

PMID: 39875356 PMC: 11775225. DOI: 10.1038/s41420-025-02308-z.

The Role and Mechanisms of Ubiquitin-Proteasome System-Mediated Ferroptosis in Neurological Disorders.

Liu X, Wang W, Nie Q, Liu X, Sun L, Ma Q Neurosci Bull. 2025; .

PMID: 39775589 DOI: 10.1007/s12264-024-01343-7.

References

Mika A, Kobiela J, Pakiet A, Czumaj A, Sokolowska E, Makarewicz W . Preferential uptake of polyunsaturated fatty acids by colorectal cancer cells. Sci Rep. 2020; 10(1):1954. PMC: 7005037. DOI: 10.1038/s41598-020-58895-7. View

Xu T, Seyfert H, Shen X . Epigenetic mechanisms contribute to decrease stearoyl-CoA desaturase 1 expression in the liver of dairy cows after prolonged feeding of high-concentrate diet. J Dairy Sci. 2017; 101(3):2506-2518. DOI: 10.3168/jds.2017-12878. View

Vriens K, Christen S, Parik S, Broekaert D, Yoshinaga K, Talebi A . Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity. Nature. 2019; 566(7744):403-406. PMC: 6390935. DOI: 10.1038/s41586-019-0904-1. View

Mou Y, Wang J, Wu J, He D, Zhang C, Duan C . Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol. 2019; 12(1):34. PMC: 6441206. DOI: 10.1186/s13045-019-0720-y. View

Chen M, Huang J . The expanded role of fatty acid metabolism in cancer: new aspects and targets. Precis Clin Med. 2019; 2(3):183-191. PMC: 6770278. DOI: 10.1093/pcmedi/pbz017. View

Li J, Condello S, Thomes-Pepin J, Ma X, Xia Y, Hurley T . Lipid Desaturation Is a Metabolic Marker and Therapeutic Target of Ovarian Cancer Stem Cells. Cell Stem Cell. 2017; 20(3):303-314.e5. PMC: 5337165. DOI: 10.1016/j.stem.2016.11.004. View

Chen R, Yung M, Xuan Y, Zhan S, Leung L, Liang R . Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells. Commun Biol. 2019; 2:281. PMC: 6668395. DOI: 10.1038/s42003-019-0508-1. View

Tesfay L, Paul B, Konstorum A, Deng Z, Cox A, Lee J . Stearoyl-CoA Desaturase 1 Protects Ovarian Cancer Cells from Ferroptotic Cell Death. Cancer Res. 2019; 79(20):5355-5366. PMC: 6801059. DOI: 10.1158/0008-5472.CAN-19-0369. View

De Luca A, Parker L, Ang W, Rodolfo C, Gabbarini V, Hancock N . A structure-based mechanism of cisplatin resistance mediated by glutathione transferase P1-1. Proc Natl Acad Sci U S A. 2019; 116(28):13943-13951. PMC: 6628828. DOI: 10.1073/pnas.1903297116. View

10.

Dalla Valle A, Vertongen P, Spruyt D, Lechanteur J, Suain V, Gaspard N . Induction of Stearoyl-CoA 9-Desaturase 1 Protects Human Mesenchymal Stromal Cells Against Palmitic Acid-Induced Lipotoxicity and Inflammation. Front Endocrinol (Lausanne). 2019; 10:726. PMC: 6822410. DOI: 10.3389/fendo.2019.00726. View

11.

Vaittinen M, Walle P, Kuosmanen E, Mannisto V, Kakela P, Agren J . FADS2 genotype regulates delta-6 desaturase activity and inflammation in human adipose tissue. J Lipid Res. 2015; 57(1):56-65. PMC: 4689336. DOI: 10.1194/jlr.M059113. View

12.

Mehlen P, Puisieux A . Metastasis: a question of life or death. Nat Rev Cancer. 2006; 6(6):449-58. DOI: 10.1038/nrc1886. View

13.

Triki M, Rinaldi G, Planque M, Broekaert D, Winkelkotte A, Maier C . mTOR Signaling and SREBP Activity Increase FADS2 Expression and Can Activate Sapienate Biosynthesis. Cell Rep. 2020; 31(12):107806. PMC: 7326293. DOI: 10.1016/j.celrep.2020.107806. View

14.

Park J, Coffey N, Limoges A, Le A . The Heterogeneity of Lipid Metabolism in Cancer. Adv Exp Med Biol. 2021; 1311:39-56. PMC: 9703268. DOI: 10.1007/978-3-030-65768-0_3. View

15.

Feng H, Stockwell B . Unsolved mysteries: How does lipid peroxidation cause ferroptosis?. PLoS Biol. 2018; 16(5):e2006203. PMC: 5991413. DOI: 10.1371/journal.pbio.2006203. View

16.

Pradas I, Huynh K, Cabre R, Ayala V, Meikle P, Jove M . Lipidomics Reveals a Tissue-Specific Fingerprint. Front Physiol. 2018; 9:1165. PMC: 6121266. DOI: 10.3389/fphys.2018.01165. View

17.

Nieman K, Kenny H, Penicka C, Ladanyi A, Buell-Gutbrod R, Zillhardt M . Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med. 2011; 17(11):1498-503. PMC: 4157349. DOI: 10.1038/nm.2492. View

18.

Pinkham K, Park D, Hashemiaghdam A, Kirov A, Adam I, Rosiak K . Stearoyl CoA Desaturase Is Essential for Regulation of Endoplasmic Reticulum Homeostasis and Tumor Growth in Glioblastoma Cancer Stem Cells. Stem Cell Reports. 2019; 12(4):712-727. PMC: 6450460. DOI: 10.1016/j.stemcr.2019.02.012. View

19.

Scott R, Manikon M, Andrews P . Actions of cisplatin on the electrophysiological properties of cultured dorsal root ganglion neurones from neonatal rats. Naunyn Schmiedebergs Arch Pharmacol. 1994; 349(3):287-94. DOI: 10.1007/BF00169295. View

20.

Mashima T, Seimiya H, Tsuruo T . De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy. Br J Cancer. 2009; 100(9):1369-72. PMC: 2694429. DOI: 10.1038/sj.bjc.6605007. View